-
2
-
-
79952101058
-
Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor
-
Qi FH, Li AY, Inagaki Y, Kokudo N, Tamura S, Nakata M, Tang W. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol 2010, 11:342-349.
-
(2010)
Int Immunopharmacol
, vol.11
, pp. 342-349
-
-
Qi, F.H.1
Li, A.Y.2
Inagaki, Y.3
Kokudo, N.4
Tamura, S.5
Nakata, M.6
Tang, W.7
-
3
-
-
57349119864
-
PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells
-
10.1097/CAD.0b013e3283160fd6, 19343001
-
Li D, Qu X, Hou K, Zhang Y, Dong Q, Teng Y, Zhang J, Liu Y. PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs 2009, 20:59-64. 10.1097/CAD.0b013e3283160fd6, 19343001.
-
(2009)
Anticancer Drugs
, vol.20
, pp. 59-64
-
-
Li, D.1
Qu, X.2
Hou, K.3
Zhang, Y.4
Dong, Q.5
Teng, Y.6
Zhang, J.7
Liu, Y.8
-
4
-
-
57349105671
-
Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells
-
10.1111/j.1349-7006.2008.00966.x, 19037992
-
Yu CH, Kan SF, Pu HF, Jea Chien E, Wang PS. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci 2008, 99:2467-2476. 10.1111/j.1349-7006.2008.00966.x, 19037992.
-
(2008)
Cancer Sci
, vol.99
, pp. 2467-2476
-
-
Yu, C.H.1
Kan, S.F.2
Pu, H.F.3
Jea Chien, E.4
Wang, P.S.5
-
5
-
-
80052746970
-
Bufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 Cells
-
3136247, 19592481
-
Sun L, Chen T, Wang X, Chen Y, Wei X. Bufalin induces reactive oxygen species dependent bax translocation and apoptosis in ASTC-a-1 Cells. Evid Based Complement Alternat Med 2011, 2011:249090. 3136247, 19592481.
-
(2011)
Evid Based Complement Alternat Med
, vol.2011
, pp. 249090
-
-
Sun, L.1
Chen, T.2
Wang, X.3
Chen, Y.4
Wei, X.5
-
6
-
-
34447321283
-
Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice
-
Han KQ, Huang G, Gu W, Su YH, Huang XQ, Ling CQ. Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol 2007, 13:3374-3379.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 3374-3379
-
-
Han, K.Q.1
Huang, G.2
Gu, W.3
Su, Y.H.4
Huang, X.Q.5
Ling, C.Q.6
-
7
-
-
46449105600
-
Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells
-
Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med 2008, 21:637-643.
-
(2008)
Int J Mol Med
, vol.21
, pp. 637-643
-
-
Takai, N.1
Ueda, T.2
Nishida, M.3
Nasu, K.4
Narahara, H.5
-
8
-
-
84867880308
-
MicroRNA regulatory networks and human disease
-
10.1007/s00018-012-1123-1, 3475759, 22926413
-
Mo YY. MicroRNA regulatory networks and human disease. Cell Mol Life Sci 2012, 69:3529-3531. 10.1007/s00018-012-1123-1, 3475759, 22926413.
-
(2012)
Cell Mol Life Sci
, vol.69
, pp. 3529-3531
-
-
Mo, Y.Y.1
-
9
-
-
67650711156
-
MicroRNAs in Cancer
-
10.1146/annurev.med.59.053006.104707, 19630570
-
Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009, 60:167-179. 10.1146/annurev.med.59.053006.104707, 19630570.
-
(2009)
Annu Rev Med
, vol.60
, pp. 167-179
-
-
Garzon, R.1
Calin, G.A.2
Croce, C.M.3
-
10
-
-
77955970299
-
MicroRNA and cancer
-
10.1208/s12248-010-9194-0, 2895440, 20422339
-
Li MF, Li J, Ding XF, He M, Cheng SY. microRNA and cancer. AAPS J 2010, 12:309-317. 10.1208/s12248-010-9194-0, 2895440, 20422339.
-
(2010)
AAPS J
, vol.12
, pp. 309-317
-
-
Li, M.F.1
Li, J.2
Ding, X.F.3
He, M.4
Cheng, S.Y.5
-
11
-
-
70349976210
-
MicroRNAs: novel regulators in the hallmarks of human cancer
-
10.1016/j.canlet.2009.04.031, 19464788
-
Ruan K, Fang XG, Ouyang GL. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009, 285:116-126. 10.1016/j.canlet.2009.04.031, 19464788.
-
(2009)
Cancer Lett
, vol.285
, pp. 116-126
-
-
Ruan, K.1
Fang, X.G.2
Ouyang, G.L.3
-
12
-
-
0346727524
-
MicroRNAs modulate hematopoietic lineage differentiation
-
10.1126/science.1091903, 14657504
-
Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86. 10.1126/science.1091903, 14657504.
-
(2004)
Science
, vol.303
, pp. 83-86
-
-
Chen, C.Z.1
Li, L.2
Lodish, H.F.3
Bartel, D.P.4
-
13
-
-
53049107572
-
Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
-
Shi L, Cheng ZH, Zhang JX, Li R, Zhao P, Fu Z, You YP. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 2008, 1236:185-193.
-
(2008)
Brain Res
, vol.1236
, pp. 185-193
-
-
Shi, L.1
Cheng, Z.H.2
Zhang, J.X.3
Li, R.4
Zhao, P.5
Fu, Z.6
You, Y.P.7
-
14
-
-
84858005054
-
MiR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes
-
3250561, 21958558
-
Ouyang YB, Lu Y, Yue S, Giffard RG. miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 2011, 12:213-219. 3250561, 21958558.
-
(2011)
Mitochondrion
, vol.12
, pp. 213-219
-
-
Ouyang, Y.B.1
Lu, Y.2
Yue, S.3
Giffard, R.G.4
-
15
-
-
84863105116
-
MiR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis
-
10.1007/s00432-011-1137-3, 22209977
-
Bai H, Cao Z, Deng C, Zhou L, Wang C. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis. J Cancer Res Clin Oncol 2012, 138:595-602. 10.1007/s00432-011-1137-3, 22209977.
-
(2012)
J Cancer Res Clin Oncol
, vol.138
, pp. 595-602
-
-
Bai, H.1
Cao, Z.2
Deng, C.3
Zhou, L.4
Wang, C.5
-
16
-
-
77949445582
-
MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2
-
Chen G, Zhu W, Shi DZ, Lv L, Zhang C, Liu P, Hu WX. MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep 2010, 23:997-1003.
-
(2010)
Oncol Rep
, vol.23
, pp. 997-1003
-
-
Chen, G.1
Zhu, W.2
Shi, D.Z.3
Lv, L.4
Zhang, C.5
Liu, P.6
Hu, W.X.7
-
17
-
-
77950203807
-
MiR-181a and miR-630 regulate cisplatin-induced cancer cell death
-
10.1158/0008-5472.CAN-09-3112, 20145152
-
Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupe P, Robert T, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 2010, 70:1793-1803. 10.1158/0008-5472.CAN-09-3112, 20145152.
-
(2010)
Cancer Res
, vol.70
, pp. 1793-1803
-
-
Galluzzi, L.1
Morselli, E.2
Vitale, I.3
Kepp, O.4
Senovilla, L.5
Criollo, A.6
Servant, N.7
Paccard, C.8
Hupe, P.9
Robert, T.10
-
18
-
-
84863276383
-
MiR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
-
10.1093/abbs/gmr128, 22285729
-
Li H, Hui LL, Xu WL. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2. Acta Biochim Biophys Sin (Shanghai) 2012, 44:269-277. 10.1093/abbs/gmr128, 22285729.
-
(2012)
Acta Biochim Biophys Sin (Shanghai)
, vol.44
, pp. 269-277
-
-
Li, H.1
Hui, L.L.2
Xu, W.L.3
-
19
-
-
84865164499
-
MiR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes
-
10.1093/carcin/bgs179, 22610076
-
Zhu DX, Zhu W, Fang C, Fan L, Zou ZJ, Wang YH, Liu P, Hong M, Miao KR, Xu W, Li JY. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis 2012, 33:1294-1301. 10.1093/carcin/bgs179, 22610076.
-
(2012)
Carcinogenesis
, vol.33
, pp. 1294-1301
-
-
Zhu, D.X.1
Zhu, W.2
Fang, C.3
Fan, L.4
Zou, Z.J.5
Wang, Y.H.6
Liu, P.7
Hong, M.8
Miao, K.R.9
Xu, W.10
Li, J.Y.11
-
20
-
-
77955619456
-
MiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
-
10.1002/ijc.25260, 20162574
-
Zhu W, Shan X, Wang TS, Shu YQ, Liu P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int J Cancer 2010, 127:2520-2529. 10.1002/ijc.25260, 20162574.
-
(2010)
Int J Cancer
, vol.127
, pp. 2520-2529
-
-
Zhu, W.1
Shan, X.2
Wang, T.S.3
Shu, Y.Q.4
Liu, P.5
-
21
-
-
84863357550
-
MiR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML)
-
10.1371/journal.pone.0032834, 3307705, 22442671
-
Fei J, Li Y, Zhu X, Luo X. miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS One 2012, 7:e32834. 10.1371/journal.pone.0032834, 3307705, 22442671.
-
(2012)
PLoS One
, vol.7
-
-
Fei, J.1
Li, Y.2
Zhu, X.3
Luo, X.4
-
22
-
-
77949261485
-
MicroRNAs in cancer - from research to therapy
-
Cho WC. MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 1805, 2009:209-217.
-
(1805)
Biochim Biophys Acta
, vol.2009
, pp. 209-217
-
-
Cho, W.C.1
-
23
-
-
0029115595
-
Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells
-
10.1016/0145-2126(95)00031-I, 7658701
-
Masuda Y, Kawazoe N, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res 1995, 19:549-556. 10.1016/0145-2126(95)00031-I, 7658701.
-
(1995)
Leuk Res
, vol.19
, pp. 549-556
-
-
Masuda, Y.1
Kawazoe, N.2
Nakajo, S.3
Yoshida, T.4
Kuroiwa, Y.5
Nakaya, K.6
-
24
-
-
15844376168
-
The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells
-
10.1074/jbc.271.24.14067, 8662906
-
Watabe M, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. The cooperative interaction of two different signaling pathways in response to bufalin induces apoptosis in human leukemia U937 cells. J Biol Chem 1996, 271:14067-14072. 10.1074/jbc.271.24.14067, 8662906.
-
(1996)
J Biol Chem
, vol.271
, pp. 14067-14072
-
-
Watabe, M.1
Masuda, Y.2
Nakajo, S.3
Yoshida, T.4
Kuroiwa, Y.5
Nakaya, K.6
-
25
-
-
0032510110
-
Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells
-
10.1038/sj.onc.1201592, 9488042
-
Watabe M, Ito K, Masuda Y, Nakajo S, Nakaya K. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene 1998, 16:779-787. 10.1038/sj.onc.1201592, 9488042.
-
(1998)
Oncogene
, vol.16
, pp. 779-787
-
-
Watabe, M.1
Ito, K.2
Masuda, Y.3
Nakajo, S.4
Nakaya, K.5
-
26
-
-
0030855164
-
Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells
-
Watabe M, Kawazoe N, Masuda Y, Nakajo S, Nakaya K. Bcl-2 protein inhibits bufalin-induced apoptosis through inhibition of mitogen-activated protein kinase activation in human leukemia U937 cells. Cancer Res 1997, 57:3097-3100.
-
(1997)
Cancer Res
, vol.57
, pp. 3097-3100
-
-
Watabe, M.1
Kawazoe, N.2
Masuda, Y.3
Nakajo, S.4
Nakaya, K.5
-
27
-
-
84875626667
-
Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial
-
Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J, Qin X, Li LQ, Ling CQ. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. J Integr Med 2013, 2:90-100.
-
(2013)
J Integr Med
, vol.2
, pp. 90-100
-
-
Zhai, X.F.1
Chen, Z.2
Li, B.3
Shen, F.4
Fan, J.5
Zhou, W.P.6
Yang, Y.K.7
Xu, J.8
Qin, X.9
Li, L.Q.10
Ling, C.Q.11
|